Loading...
 
Toggle Health Problems and D

Respiratory Virus risk reduced 35 percent by Vitamin D (14,000 IU weekly) – RCT Oct 2018

Effect of Vitamin D supplementation to reduce respiratory infections in children and adolescents in Vietnam: a randomized controlled trial.

Influenza Other Respir Viruses. 2018 Oct 16. doi: 10.1111/irv.12615. [Epub ahead of print]
Loeb M1 loebm at mcmaster.ca , Dang AD2, Thiem VD3, Thanabalan V4, Wang B4, Nguyen NB5, Tran HTM2, Luong TM2, Singh P4, Smieja M4, Maguire J6, Pullenayegum E7.

VitaminDWiki

Comments on the study by VitaminDWiki

  1. They appeared to start counting the infections immediately after starting the vitamin D, rather than waiting 4-6 months for the blood levels to plateau
  2. Virtually all of the children had a high level of vitamin D to start with, so raising it even more should not be expected to result in a large benefit
  3. They used the amount of Vitamin D independent of age/weight
    Suspect that at least 2800 IU Vitamin D would be needed for the older/heavier children
  • Suspect > 50% reduction if
    had used more Vitamin D (to get most about 40 ng),
    had started before flu season,
    had used dose size was proportional to weight,
    children did not have such a high level to start with


Breathing category starts with the following

445 items in Breathing category

Breathing-related Overviews at VitaminDWiki:
Allergy   Lung Cancer   TB   Asthma  Influenza  Colds and flu
Pneumonia   Respiratory infections   COPD   Air Polution   Smoking   Cystic Fibrosis


All of the studies in Breathing and Virus are listed here:

 Download the PDF from VitaminDWiki

BACKGROUND: It is uncertain whether Vitamin D can reduce respiratory infection.

OBJECTIVE: To determine if vitamin D supplementation reduces influenza and other upper viral respiratory tract infections.

METHODS:
1,300 healthy children and adolescents between the ages of 3 and 17 years were randomized to vitamin D (14,000U weekly) or placebo for eight months in Vietnam. The primary outcome was reverse transcriptase (RT) -PCR confirmed influenza infection and the co-primary outcome was multiplex PCR confirmed non-influenza respiratory viruses. Participants, care givers, and those assessing outcomes were blinded to group assignment.

RESULTS:
650 children and adolescents were randomly assigned to vitamin D and 650 to placebo. The mean baseline serum 25-hydroxyvitamin D levels were 65.7 nmol/L and 65.2 nmol/L in the intervention and placebo groups respectively, with an increase to 91.8 nmol/L in the vitamin D group and no increase, 64.5 nmol/L, in the placebo group. All 1,300 participants randomized contributed to the analysis.
We observed RT-PCR confirmed influenza A or B occurred in 50 children (7.7%) in the vitamin D group and in 43 (6.6%) in the placebo group (hazard ratio [HR] 1.18, 95%CI 0.79 to 1.78). RT-PCR confirmed non-influenza respiratory virus infection occurred in 146 (22.5%) in the vitamin D group and in 185 (28.5%) in the placebo group (hazard ratio [HR] 0.76, 95% CI 0.61 to 0.94). When considering all respiratory viruses, including influenza, the effect of vitamin D in reducing infection was significant, HR 0.81, 95% CI 0.66 to 0.99.

CONCLUSION: Vitamin D supplementation did not reduce the incidence of influenza but moderately reduced non-influenza respiratory viral infection.

Snips from PDF

  • “One possible limitation was the use of oropharyngeal specimens instead of nasopharyneal specimens. This was based on adherence to testing and we reasoned that an increase in the number of swabs would make up for any reduction in sensitivity.”
  • “Only 17% of participants in our study had vitamin D levels < 50 nmol/L, in contrast to a previous study from Vietnam where > 50% children had insufficiency or deficiency (23). The relatively high vitamin D levels in our study may have reduced the effectiveness of vitamin D supplementation in preventing influenza. “

Non-influenza virus infection

Vitamin D PlaceboReduction in risk
Year 1 27.0%37.50%0.65
Year 2 20.4%24.4% 0.82

Virus Vitamin D Placebo
≥ 1 virus 27.2%32.2%
Influenza A 6.2%4.5%
Influenza B 1.7%2.3%
Adenovirus 1.5%1.7%
MPV1.8%3.8%
RSV 1.1%1.5%

Created by admin. Last Modification: Monday March 2, 2020 00:22:43 GMT-0000 by admin. (Version 10)

Attached files

ID Name Comment Uploaded Size Downloads
10707 Respiratory Virus RCT.pdf admin 18 Oct, 2018 615.72 Kb 756